Joint United Nations Programme on HIV/AIDS. UNAIDS DATA 2022 [Internet]. Geneva; 2022. https://www.unaids.org/en/resources/documents/2023/2022_unaids_data. Accessed 9 June 2023.
Verdin E, Paras P, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 1993;12:3249–59.
Article CAS PubMed Central PubMed Google Scholar
Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, et al. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol. 2008;82:12291–303.
Article CAS PubMed Central PubMed Google Scholar
Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. Epigenetic regulation of HIV-1 latency by cytosine methylation. Ross S, editor. PLoS Pathog. 2009;5:e1000495.
Tyagi M, Pearson RJ, Karn J. Establishment of HIV latency in primary CD4 + cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol. 2010;84:6425–37.
Article CAS PubMed Central PubMed Google Scholar
Einkauf KB, Lee GQ, Gao C, Sharaf R, Sun X, Hua S, et al. Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy. J Clin Invest. 2019;129:988–98.
Article PubMed Central PubMed Google Scholar
Patro SC, Brandt LD, Bale MJ, Halvas EK, Joseph KW, Shao W, et al. Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors. Proc Natl Acad Sci. 2019;116:25891–9.
Article CAS PubMed Central PubMed Google Scholar
Sun C, Liu L, Pérez L, Li X, Liu Y, Xu P, et al. Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy. Nat Biomed Eng. 2022;6:1004–12.
Article CAS PubMed Central PubMed Google Scholar
• Lindqvist B, Jütte BB, Love L, Assi W, Roux J, Sönnerborg A, et al. T cell stimulation remodels the latently HIV-1 infected cell population by differential activation of proviral chromatin. PLoS Pathog. 2022;18:e1010555. Study pioneering the proximity ligation assay (PLA) based technique to assess the proviral chromatin environment in single cells to understand its impact on the HIV-1 reactivation potential.
• Sun W, Gao C, Hartana CA, Osborn MR, Einkauf KB, Lian X, et al. Phenotypic signatures of immune selection in HIV-1 reservoir cells. Nature. 2023;614:309–17. Recent study demonstrating that cells harboring intact HIV-1 proviruses frequently express surface markers associated with resistance to immune-mediated killing.
Robb ML, Eller LA, Kibuuka H, Rono K, Maganga L, Nitayaphan S, et al. Prospective study of acute HIV-1 infection in adults in East Africa and Thailand. N Engl J Med. 2016;374:2120–30.
Article CAS PubMed Central PubMed Google Scholar
Coffin JM, Wells DW, Zerbato JM, Kuruc JD, Guo S, Luke BT, et al. Clones of infected cells arise early in HIV-infected individuals. JCI Insight. 2019;4:e128432.
Article PubMed Central PubMed Google Scholar
• Gantner P, Buranapraditkun S, Pagliuzza A, Dufour C, Pardons M, Mitchell JL, et al. HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections. Immunity. 2023;56:653–668.e5. Study demonstrating that targets of the early HIV-1 infection change rapidly and the latent proviral reservoir is archived from the earliest stages of infection.
Zhang Z-Q, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4 + T Cells. Science. 1999;286:1353–7.
Article CAS PubMed Google Scholar
Saleh S, Solomon A, Wightman F, Xhilaga M, Cameron PU, Lewin SR. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood. 2007;110:4161–4.
Article CAS PubMed Google Scholar
Cameron PU, Saleh S, Sallmann G, Solomon A, Wightman F, Evans VA, et al. Establishment of HIV-1 latency in resting CD4 + T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci. 2010;107:16934–9.
Article CAS PubMed Central PubMed Google Scholar
•• Leyre L, Kroon E, Vandergeeten C, Sacdalan C, Colby DJ, Buranapraditkun S, et al. Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection. Sci Transl Med. 2020;12:eaav3491. A longitudinal study showing that lymphoid tissues contain a higher number of latently infected cells than blood. ART initiation at early Fiebig stages I to III was most effective at clearing HIV-1 infected cells.
Perreau M, Savoye A-L, De Crignis E, Corpataux J-M, Cubas R, Haddad EK, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210:143–56.
Article CAS PubMed Central PubMed Google Scholar
Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997;94:13193–7.
Article CAS PubMed Central PubMed Google Scholar
Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278:1295–300.
Article CAS PubMed Google Scholar
Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278:1291–5.
Article CAS PubMed Google Scholar
•• Veenhuis RT, Abreu CM, Costa PAG, Ferreira EA, Ratliff J, Pohlenz L, et al. Monocyte-derived macrophages contain persistent latent HIV reservoirs. Nat Microbiol. 2023;8:833–844. HIV-1 containing macrophages are able to infect bystander cells in a quantitative viral outgrowth assay.
Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S, Smith AG, et al. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci Transl Med. 2021;13:eabd8179.
Article CAS PubMed Central PubMed Google Scholar
Beignon A-S, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest. 2005;115:3265–75.
Article CAS PubMed Central PubMed Google Scholar
Lim S-Y, Osuna CE, Hraber PT, Hesselgesser J, Gerold JM, Barnes TL, et al. TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy. Sci Transl Med. 2018;10:eaao4521.
Article PubMed Central PubMed Google Scholar
• SenGupta D, Brinson C, DeJesus E, Mills A, Shalit P, Guo S, et al. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy. Sci Transl Med. 2021;13:eabg3071. An analytical treatment interruption study showing that TRL7 agonist increased time to rebound and reduced the frequency of cells harboring intact virus.
Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002;417:95–8.
Article CAS PubMed Google Scholar
Zila V, Margiotta E, Turoňová B, Müller TG, Zimmerli CE, Mattei S, et al. Cone-shaped HIV-1 capsids are transported through intact nuclear pores. Cell. 2021;184:1032-1046.e18.
Article CAS PubMed Central PubMed Google Scholar
Geis FK, Goff SP. Unintegrated HIV-1 DNAs are loaded with core and linker histones and transcriptionally silenced. Proc Natl Acad Sci. 2019;116:23735–42.
Article CAS PubMed Central PubMed Google Scholar
Schröder ARW, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521–9.
Wang GP, Ciuffi A, Leipzig J, Berry CC, Bushman FD. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 2007;17:1186–94.
Article CAS PubMed Central PubMed Google Scholar
Battivelli E, Dahabieh MS, Abdel-Mohsen M, da Svensson JP, Silva IT, Cohn LB, et al. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells. ELife. 2018;7:e34655.
Article PubMed Central PubMed Google Scholar
Sapp N, Burge N, Cox K, Prakash P, Balasubramaniam M, Thapa S, et al. HIV-1 Preintegration complex preferentially integrates the viral DNA into nucleosomes containing trimethylated histone 3-lysine 36 modification and flanking linker DNA. J Virol. 2022;96:e0101122.
Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, et al. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med. 2005;11:1287–9.
Article CAS PubMed Google Scholar
Shan L, Deng K, Gao H, Xing S, Capoferri AA, Durand CM, et al. Transcriptional reprogramming during effector-to-memory transition renders CD4+ T cells permissive for latent HIV-1 infection. Immunity. 2017;47:766-775.e3.
Article CAS PubMed Central PubMed Google Scholar
• Irwan ID, Bogerd HP, Cullen BR. Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency. Nat Microbiol. 2022;7:2101–13. The structural maintenance of chromosome (SMC) 5/6 is shown to silence unintegrated HIV-1 by SUMOlation of unintegrated chromatinized HIV-1 DNA.
Chen H-C, Martinez JP, Zorita E, Meyerhans A, Filion GJ. Position effects influence HIV latency reversal. Nat Struct Mol Biol. 2017;24:47–54.
Article CAS PubMed Google Scholar
Pradhan B, Kanno T, Umeda Igarashi M, Loke MS, Baaske MD, Wong JSK, et al. The Smc5/6 complex is a DNA loop-extruding motor. Nature. 2023;616:843–8.
Article CAS PubMed Central PubMed Google Scholar
Betts Lindroos H, Ström L, Itoh T, Katou Y, Shirahige K, Sjögren C. Chromosomal association of the Smc5/6 complex reveals that it functions in differently regulated pathways. Mol Cell. 2006;22:755–67.
Kegel A, Betts-Lindroos H, Kanno T, Jeppsson K, Ström L, Katou Y, et al. Chromosome length influences replication-induced topological stress. Nature. 2011;471:392–6.
Comments (0)